RXSIGHT INC's ticker is and the CUSIP is 78349D107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,953 | +759.9% | 3,046 | +788.0% | 0.00% | – |
| Q2 2023 | $9,879 | +109666.7% | 343 | -39.1% | 0.00% | – |
| Q1 2023 | $9 | 0.0% | 563 | -23.0% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 731 | -37.8% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 1,175 | +17.0% | 0.00% | – |
| Q2 2022 | $14,000 | +7.7% | 1,004 | -2.3% | 0.00% | – |
| Q1 2022 | $13,000 | -43.5% | 1,028 | -48.9% | 0.00% | – |
| Q4 2021 | $23,000 | +155.6% | 2,010 | +196.9% | 0.00% | – |
| Q3 2021 | $9,000 | – | 677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Divisadero Street Capital Management, LP | 680,000 | $18,965,200 | 5.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 747,827 | $20,856,895 | 2.27% |
| Parkman Healthcare Partners LLC | 381,331 | $10,635,322 | 1.95% |
| Atika Capital Management LLC | 509,352 | $14,205,828 | 1.86% |
| RA Capital Management | 3,052,796 | $85,142,480 | 1.68% |
| EAM Investors, LLC | 163,168 | $4,550,756 | 0.88% |
| No Street GP LP | 250,000 | $6,972,500 | 0.83% |
| ADVISORY RESEARCH INC | 156,189 | $4,356,112 | 0.60% |
| Lisanti Capital Growth, LLC | 123,205 | $3,436,187 | 0.54% |
| Alpha DNA Investment Management LLC | 20,879 | $582,315 | 0.24% |